Oncology

Male sex and Hispanic ethnicity increase early-onset colorectal cancer risk, while foreign maternal birthplace provides protection.

FEXOFENADINE in cancer models exhibits significant concentration-dependent cytotoxic effects by disrupting mitochondrial homeostasis and pro-survival pathways.

Latest global cancer statistics show a surging disease burden that demands aggressive primary prevention strategies globally.

A retrospective cohort study associated GLP-1 agonists with a significant reduction in female breast cancer incidence.

Active surveillance pathways for men with low-risk prostate cancer are increasingly utilizing concurrent hormonal treatment strategies.

A new meta-analysis evaluates neoadjuvant bladder cancer therapy options for patients. Read more to discover the optimal treatment protocols.

Precision medicine is reshaping first line treatment for advanced gastric cancer through biomarker guided therapy selection.

GLP-1 receptor agonists may reduce obesity related cancer risk. Read more about the latest evidence on AMJ.